Cosentyx 300 MG dose-2 syringeml
Ended Awarded
- Contract number
- SPE2DB26FXHKB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,242
Award facts
- Contract value 100% obligated
- $34,241.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,241.54 for Cosentyx 300 mg dose syringes on November 4, 2025, with completion targeted for November 5, 2025. This firm fixed-price contract, which is not set-aside, represents a competitive award to support federal pharmaceutical supply needs. The award was made under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and running through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. Cosentyx is a specialty biologic medication used to treat autoimmune conditions and is among the company's portfolio of brand-name and generic drugs, vaccines, and specialized medical supplies delivered through federal contracts. The delivery order demonstrates the company's capability to fulfill specialized pharmaceutical requirements through the DLA's established pharmaceutical supply chain, which is undergoing evolution with the planned Pharmaceutical Prime Vendor Global Program Generation V contracts intended to involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DB26FXHKB?
SPE2DB26FXHKB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FXHKB worth?
The government has obligated $34,242 on SPE2DB26FXHKB.
Is contract SPE2DB26FXHKB an order under another contract?
Yes. SPE2DB26FXHKB is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHKB competed?
The extent of competition for SPE2DB26FXHKB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award